Please login to the form below

Not currently logged in
Email:
Password:

Pliva finalises German oncology business acquisition

Pliva reveals that its German subsidiary AWD Pharma signed an agreement to acquire ORCA Pharm, a privately owned pharmaceutical company with a presence in the oncology market in that region

Croatia-headquartered Pliva has revealed that its German subsidiary AWD Pharma has signed an agreement to acquire ORCA Pharm, a privately owned pharmaceutical company with a presence in the oncology market in that region.

When the transaction is closed, AWD will pay a fixed purchase price of EUR 21m and up to an additional EUR 13m, based on the achievement of profitability milestones for 2007 and 2008.

Zeljko Covic, President and COO of Pliva, said: "Our acquisition of ORCA pharm provides us with a strategic platform for entering the highly lucrative oncology business in Germany and strongly supports our corporate strategy of focusing on markets with greater barriers-to-entry and thus greater value."

"The acquisition of ORCA pharm and its current product portfolio further supports our commitment to the EU oncology market and strengthens the foothold we have already established through our Czech subsidiary PLIVA Lachema, which focuses on the development, production and distribution of vertically integrated injectable cytostatic products," concluded Covic.

30th September 2008

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Nucleus Global

Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 800 experts delivering world-class...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...